RetinalGenix Technologies Inc.
RTGN
$4.00
$0.8025.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -8.73% | -40.63% | -31.41% | -32.62% | -26.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.00% | -43.84% | -33.14% | -31.97% | -25.89% |
| Operating Income | 12.00% | 43.84% | 33.14% | 31.97% | 25.89% |
| Income Before Tax | 11.96% | 43.79% | 33.11% | 31.94% | 25.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.96% | 43.79% | 33.11% | 31.94% | 25.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.96% | 43.79% | 33.11% | 31.94% | 25.87% |
| EBIT | 12.00% | 43.84% | 33.14% | 31.97% | 25.89% |
| EBITDA | 11.99% | 43.84% | 33.15% | 31.98% | 25.90% |
| EPS Basic | 14.22% | 45.89% | 35.42% | 34.18% | 28.12% |
| Normalized Basic EPS | 14.17% | 45.90% | 35.39% | 34.17% | 28.13% |
| EPS Diluted | 14.22% | 45.89% | 35.42% | 34.18% | 28.12% |
| Normalized Diluted EPS | 14.17% | 45.90% | 35.39% | 34.17% | 28.13% |
| Average Basic Shares Outstanding | 2.48% | 3.37% | 3.49% | 3.65% | 3.86% |
| Average Diluted Shares Outstanding | 2.48% | 3.37% | 3.49% | 3.65% | 3.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |